Antibacterial Drugs Market is Anticipated to Reach a Value of US$ 51,447.6 Mn by 2025

1
Drug Class - B - lactams, Quinolones, Macrolides,
Tetracycline, Aminoglycoside, Sulfonamide, and
Phenicols Routes of Administration - Enteral and
Parenteral Distribution Channel - Hospital
Pharmacies, Drug Stores and Retail Pharmacies,
and Online SalesForecast 2017 - 2025
Antibacterial Drugs Market
2
Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Research Methodology
Chapter 3 Executive Summary
Chapter 4 Market Overview
Chapter 5 Global Antibacterial Drugs Market Analysis, by Drug Class, 2015 2025
Chapter 6 Global Antibacterial Drugs Market Analysis, by Routes of Administration
Chapter 7 Global Antibacterial Drugs Market Analysis, by Channels of Distribution
Chapter 8 Global Antibacterial Drugs Market Analysis, by Region
Chapter 9 North America Antibacterial Drugs Market Analysis
Chapter 10 Europe Antibacterial Drugs Market Analysis
Chapter 11 Asia Pacific Antibacterial Drugs Market Analysis
Chapter 12 Latin America Antibacterial Drugs Market Analysis
Chapter 13 Middle East Africa Antibacterial Drugs Market Analysis
Chapter 14 Competition Landscape

3
Antibacterial Drugs Market Snapshot

• Antibacterial drugs are the chemical substances
  which are derived from bacterium to cure
  bacterial infections. The global antibacterial
  drugs market is driven by the rapidly growing
  antibacterial resistance and demand for new broad
  spectrum agents.
• Market revenue is provided in terms of US Mn
  from 2015 to 2025 along with the compound annual
  growth rate (CAGR ) from 2017 to 2025 for all
  the segments, considering 2016 as the base year
• Product innovations, improving product portfolio,
  and geographical expansion will also be seen as
  important business strategies by these vendors in
  the market.
• Leading players in the global antibacterial drugs
  market include Novartis AG, Allergan, Plc.,
  Bristol Myers Squibb Company AstraZeneca, Johnson
  and Johnson, Merck Co., Inc.,

4
(No Transcript)
5
Reports Highlights

• The global antibacterial drugs market registered
  at US45,325.0 mn in 2016 and is anticipated to
  reach a value of US51,447.6 mn by the end of the
  2025. The market is expected to witness a steady
  CAGR of 1.5 over the forecast period from 2017
  to 2025.
• Growing initiatives by numerous governments and
  key players for the commercialization of
  therapies are expected to bolster the growth of
  the market. These initiatives have conducted
  advancements in enteral routes of administration
  and available across numerous developing and
  developed counties are expected to the uptake of
  antibacterial drugs.
• Technological advancements through innovative
  formulations of drug are expected to boost
  adoption of drugs and create potential growth
  opportunities for the antibacterial drugs market.
• Rise High with Rapid Development of
  Biopharmaceutical Sector.

Request Sample
6
(No Transcript)